GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » Market Cap

Gentian Diagnostics AS (OSL:GENT) Market Cap : kr715.6 Mil (As of Apr. 03, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Gentian Diagnostics AS's share price for the quarter that ended in Dec. 2024 was kr39.2. Gentian Diagnostics AS's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 15.4 Mil. Therefore, Gentian Diagnostics AS's market cap for the quarter that ended in Dec. 2024 was kr604.5 Mil.

Gentian Diagnostics AS's quarterly market cap declined from Jun. 2024 (kr832.8 Mil) to Sep. 2024 (kr669.3 Mil) and declined from Sep. 2024 (kr669.3 Mil) to Dec. 2024 (kr604.5 Mil).

Gentian Diagnostics AS's annual market cap increased from Dec. 2022 (kr632.3 Mil) to Dec. 2023 (kr640.0 Mil) but then declined from Dec. 2023 (kr640.0 Mil) to Dec. 2024 (kr604.5 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Gentian Diagnostics AS's Enterprise Value for Today is kr640.9 Mil.


Gentian Diagnostics AS Market Cap Historical Data

The historical data trend for Gentian Diagnostics AS's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS Market Cap Chart

Gentian Diagnostics AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 839.95 1,110.38 632.30 640.01 604.54

Gentian Diagnostics AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 640.01 598.37 832.79 669.31 604.54

Competitive Comparison of Gentian Diagnostics AS's Market Cap

For the Medical Devices subindustry, Gentian Diagnostics AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gentian Diagnostics AS's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gentian Diagnostics AS's Market Cap distribution charts can be found below:

* The bar in red indicates where Gentian Diagnostics AS's Market Cap falls into.


;
;

Gentian Diagnostics AS Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Gentian Diagnostics AS's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=kr39.2*15.422
=kr604.5

Gentian Diagnostics AS's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=kr39.2*15.422
=kr604.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gentian Diagnostics AS  (OSL:GENT) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Gentian Diagnostics AS Market Cap Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Gentian Diagnostics AS Business Description

Traded in Other Exchanges
N/A
Address
Bjornasveien 5, Moss, NOR, 1596
Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.

Gentian Diagnostics AS Headlines